Filing Details

Accession Number:
0001214659-22-003108
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-23 18:03:25
Reporting Period:
2022-02-18
Accepted Time:
2022-02-23 18:03:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1581280 Twist Bioscience Corp TWST () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1252038 M James Thorburn C/O Twist Bioscience Corporation
681 Gateway Blvd.
South San Francisco CA 94080
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-02-18 1,025 $53.21 47,925 No 4 F Direct
Common Stock Acquisiton 2022-02-22 1,517 $26.66 49,442 No 4 M Direct
Common Stock Acquisiton 2022-02-22 2,000 $23.33 51,442 No 4 M Direct
Common Stock Disposition 2022-02-22 2,461 $52.03 48,981 No 4 S Direct
Common Stock Disposition 2022-02-22 1,341 $52.88 47,640 No 4 S Direct
Common Stock Disposition 2022-02-22 640 $53.66 47,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2022-02-22 1,517 $0.00 1,517 $26.66
Common Stock Employee Stock Option (right to buy) Disposition 2022-02-22 2,000 $0.00 2,000 $23.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
41,898 2028-11-18 No 4 M Direct
27,748 2029-10-23 No 4 M Direct
Footnotes
  1. Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
  2. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 24, 2021.
  3. Represents the weighted average sales price per share. The shares sold at prices ranging from $51.44 to $52.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  4. Represents the weighted average sales price per share. The shares sold at prices ranging from $52.45 to $53.36 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  5. Represents the weighted average sales price per share. The shares sold at prices ranging from $53.50 to $54.09 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  6. 20% of the shares subject to the option vested and became exercisable on October 31, 2019, and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
  7. 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.